Process for the synthesis and crystalline form agomelatine
US7544839B2 · kind B2 · utility
5Cited by
2References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 6, 2007 |
| Grant date | Jun 9, 2009 |
| Priority date | — |
| Expiry date | Apr 16, 2027 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02E10/72
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Process for the industrial synthesis and new crystalline form of the compound of formula (I):Medicinal products containing the same which are useful in treating disorders of the melatoninergic system.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.